Journal article
The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT): Study protocol
Abstract
BACKGROUND: The implantable cardioverter/defibrillator (ICD) has been shown to be superior to antiarrhythmic drug therapy for the secondary prevention of sudden cardiac death. Its role in the primary prevention of sudden death after myocardial infarction is unknown. Methods and Results The Defibrillator in Acute Myocardial Infarction Trial (DINAMIT) is a randomized, open-label, parallel-group comparison of ICD therapy versus no ICD therapy in …
Authors
Hohnloser SH; Connolly SJ; Kuck KH; Dorian P; Fain E; Hampton JR; Hatala R; Pauly AC; Roberts RS; Themeles E
Journal
American Heart Journal, Vol. 140, No. 5, pp. 735–739
Publisher
Elsevier
Publication Date
November 2000
DOI
10.1067/mhj.2000.110088
ISSN
0002-8703